Nalaganje...

Efficacy of the pentavalent rotavirus vaccine, RotaTeq®, in Finnish infants up to 3 years of age: the Finnish Extension Study

Rotavirus Efficacy and Safety Trial (REST) enrolled nearly 70,000 infants, of whom more than 23,000 were from Finland. REST determined the efficacy of the pentavalent rotavirus vaccine (RV5) against rotavirus-related hospitalisations and emergency department (ED) visits in the first year after vacci...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Vesikari, Timo, Karvonen, Aino, Ferrante, Shannon Allen, Ciarlet, Max
Format: Artigo
Jezik:Inglês
Izdano: Springer-Verlag 2010
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2943584/
https://ncbi.nlm.nih.gov/pubmed/20559656
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00431-010-1242-3
Oznake: Označite
Brez oznak, prvi označite!